Express, Inc. Reports Record Second Quarter 2015 Results; Introduces Third Quarter Guidance and Raises Full Year 2015 Outlook

... Read more

Extreme Networks

... Read more

FDA Confirms a 510(k) De Novo Path for EyeGate’s Device, the Ocular Bandage

... Read more

EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of

... Read more

EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase

... Read more

EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437

... Read more

EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437

... Read more

EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial

... Read more

EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial

... Read more

EyeGate Reports Third

... Read more